Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel

L Kohan, S Potru, AM Barreveld, M Sprintz… - Regional Anesthesia & …, 2021 - rapm.bmj.com
Background The past two decades have witnessed an epidemic of opioid use disorder
(OUD) in the USA, resulting in catastrophic loss of life secondary to opioid overdoses …

Oxidative stress and neuroinflammation as a pivot in drug abuse. A focus on the therapeutic potential of antioxidant and anti-inflammatory agents and biomolecules

P Berríos-Cárcamo, M Quezada, ME Quintanilla… - Antioxidants, 2020 - mdpi.com
Drug abuse is a major global health and economic problem. However, there are no
pharmacological treatments to effectively reduce the compulsive use of most drugs of abuse …

Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention

ND Volkow, C Blanco - World Psychiatry, 2023 - Wiley Online Library
Substance use disorders (SUDs) are highly prevalent and exact a large toll on individuals'
health, well‐being, and social functioning. Long‐lasting changes in brain networks involved …

Machine-learning repurposing of DrugBank compounds for opioid use disorder

H Feng, J Jiang, GW Wei - Computers in biology and medicine, 2023 - Elsevier
Opioid use disorder (OUD) is a chronic and relapsing condition that involves the continued
and compulsive use of opioids despite harmful consequences. The development of …

Targeting opioid receptors in addiction and drug withdrawal: where are we going?

R Tabanelli, S Brogi, V Calderone - International Journal of Molecular …, 2023 - mdpi.com
This review article offers an outlook on the use of opioids as therapeutics for treating several
diseases, including cancer and non-cancer pain, and focuses the analysis on the …

[HTML][HTML] Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research

FR Mendes, C dos Santos Costa, VD Wiltenburg… - Addiction …, 2022 - Elsevier
Substance use disorder (SUD) is a global public health concern that affects millions of
people worldwide. Considering current research, addiction has been noted as the last stage …

Dopamine D3 receptor-based medication development for the treatment of opioid use disorder: Rationale, progress, and challenges

E Galaj, AH Newman, ZX Xi - Neuroscience & Biobehavioral Reviews, 2020 - Elsevier
Opioid abuse and related overdose deaths continue to rise in the United States, contributing
to the current national opioid crisis. Although several opioid-based pharmacotherapies are …

[HTML][HTML] Experiences of healthcare and substance use treatment provider-based stigma among patients receiving methadone

A Carl, E Pasman, MJ Broman, JJ Lister, E Agius… - Drug and Alcohol …, 2023 - Elsevier
Abstract Background Medications for Opioid Use Disorder (MOUD) are efficacious, however
only one-third of individuals with an opioid use disorder (OUD) enter into treatment. Low …

Machine-learning analysis of opioid use disorder informed by MOR, DOR, KOR, NOR and ZOR-based interactome networks

H Feng, R Elladki, J Jiang, GW Wei - Computers in biology and medicine, 2023 - Elsevier
Opioid use disorder (OUD) continuously poses major public health challenges and social
implications worldwide with dramatic rise of opioid dependence leading to potential abuse …

Low-dose naltrexone's utility for non-cancer centralized pain conditions: a scoping review

A Rupp, E Young, AL Chadwick - Pain Medicine, 2023 - academic.oup.com
Background At low doses, naltrexone (LDN) has been shown to modulate inflammation
through the interruption of microglial cell activation within the central nervous system. One of …